Repair the leak.
Preserve the future.
A novel approach to transcatheter repair for functional mitral regurgitation.
The leaflets may be healthy.
The heart has changed.
In functional mitral regurgitation, changes in the heart pull healthy leaflets apart, so the valve no longer closes properly.
Each heartbeat sends blood backward, adding strain to a heart that is already struggling.
2.2x
Significant mitral regurgitation more than doubles the expected risk of death.*
64%
of people with significant mitral regurgitation experience heart failure within five years.*
Today’s repair depends on leaflet anatomy
For patients at high surgical risk, transcatheter edge-to-edge repair is an established treatment, but it requires anatomy suited to a leaflet-based approach.
Some patients are not candidates for it. Others continue to have mitral regurgitation after treatment.
Mitria is developing a way to repair where leaflet anatomy limits today’s options.
Support from
beneath the valve
Mitria Medical is developing an investigational transcatheter therapy designed to support the displaced posterior leaflet from below, improve coaptation and reduce the leak, while maintaining native valve opening and preserving future treatment options.
01. Repair
One small implant, delivered by catheter, that leaves both leaflets free to move.
02. Preserve
Designed to maintain native valve opening, so it closes a leak without closing a door.
03. Reach
Being developed for a wide range of mitral anatomies, including those that limit leaflet-based repair.
Repair with the
future in mind
Our goal is to extend transcatheter repair to more patients with functional mitral regurgitation while preserving future treatment options.
September 29, 2026
Mitria Medical Partners with T45 Labs to Advance Novel Mitral Valve Repair Therapy
Read the release ⇁
March 5, 2026
Mitria Medical Announces First Use of Novel Mitral Valve Repair Device in U.S. Under Single Patient Expanded Access
Read the release ⇁